Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report)’s share price was down 6.6% on Monday . The stock traded as low as $0.6467 and last traded at $0.6603. Approximately 307,414 shares changed hands during mid-day trading, a decline of 19% from the average daily volume of 377,395 shares. The stock had previously closed at $0.7070.
Nemus Bioscience Trading Down 6.6%
The stock has a market capitalization of $88.42 million, a PE ratio of -7.34 and a beta of -0.04.
About Nemus Bioscience
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Read More
- Five stocks we like better than Nemus Bioscience
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
- Only 500 people today…
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
